The reporter learned from the Chinese Center for Disease Control and Prevention today (9th) that China has completed preclinical research on an inactivated vaccine against the delta variant
In response to the delta variant of the new coronavirus, the China Centers for Disease Control has carried out the research and development of inactivated vaccines
Wu Guizhen, chief biosafety expert of the Chinese Center for Disease Control and Prevention: We have successfully isolated a number of Delta strains from clinical samples imported from Guangdong, Shanghai, and Beijing that have a relatively large number of epidemics
Each vaccine research and development unit has also carried out research on broad-spectrum or multivalent recombinant protein vaccines against different variants of the new coronavirus; has carried out research and development of adenovirus vector vaccines and nucleic acid vaccines against beta strains and delta strains, and some units have completed Animal effectiveness and safety experiments were conducted
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
